|Type 2 Diabetes Mellitus Pilot and Feasibility Awards
January 9, 2007, Volume 53, No. 17
The Type 2 Diabetes Mellitus (T2DM) Unit of the Institute for Diabetes, Obesity, and Metabolism (IDOM) is pleased to invite applications for its Pilot and Feasibility Awards. New or established investigators who wish to pursue a novel area of research in diabetes are encouraged to submit an application by February 28, 2007.
The T2DM Unit plans to award one to two $25,000 pilot awards with the following criteria.
• Preference will be given to collaborative studies between members of the Penn community. Participation from varied schools and disciplines will be highly considered.
• Research must be in Type 2 diabetes in areas of metabolism, insulin action and secretion, and, equally importantly, encouraging productive collaborative interactions between basic scientists and clinicians.
• The award period will be for twelve months beginning July 1, 2007 and ending on June 30, 2008. Although successful applicants may apply for a second year, continuations greater than two years will not be granted.
The deadline for submission is February 28, 2007. Complete applications will only be considered and must include the following. Please note that there is a 6 page limit.
• Abstract Page—it should not be longer than 250 words
• Budget page and justification—it should summarize projected expenditures for allowable costs. These include funds for research supplies, staff and travel expense to one scientific meeting to present study results. Funds are not permitted to support applicant’s own salary.
• Background and Significance—this section should concisely summarize the pertinent literature and set the stage for the proposed study. Any pertinent pilot data or studies by the applicant should be noted. Specific aims and hypotheses should be stated.
• Research Plan—includes the following subsections: (a) Research design; (b) Subjects; (c) Subject evaluation/procedures; (d) Sample size and analyses; (e) Methodological considerations; and (f) anticipated results and future directions.
• NIH Biosketch and Other Support Pages.
• Format of submission—2 paper copies and a PDF file should be sent to: Ms. Rose Halligan 778 Clinical Research Building and by e-mail to firstname.lastname@example.org.
Full submissions will be reviewed by the IDOM Associate Director, and Director of the Type 2 Unit, Dr. Morris J. Birnbaum and the Assistant Director Dr. Nayyar Iqbal. Funding decisions will be based principally on the priority scores awarded applications. Applications will be scored and notified in May 2007. Funded applicants will be asked to provide a 2-page progress report at the conclusion of the year. The report will contain a synopsis of scientific progress, a list of resulting collaborations, publications, and grants. The Type 2 Unit of the Institute for Diabetes, Obesity & Metabolism must be acknowledged.